[1] |
Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis [J]. Am J Surg Pathol, 1983, 7(6): 507-519.
|
[2] |
金哲虎. 瘢痕疙瘩的成因及治疗新进展[J]. 中国医学文摘(皮肤科学), 2015, 32(1): 11-15+4.
|
[3] |
程飚, 付小兵, 盛志勇. 免疫因素在瘢痕形成和发展中的作用[J]. 中国临床康复, 2002, 6(4): 464-466.
|
[4] |
Harty M, Neff AW, King MW, et al. Regeneration or scarring: an immunologic perspective [J]. Dev Dyn, 2003, 226(2): 268-279.
|
[5] |
Riva G, Luppi M, Barozzi P, et al. Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+acute lymphoblastic leukemia during long-term imatinib mesylate treatment [J]. Blood, 2010, 115(8): 1512-1518.
|
[6] |
Siegers GM, Felizardo TC, Mathieson AM, et al. Anti-leukemia activity of in vitro-expanded human gamma delta T cells in a xenogeneic Ph+leukemia model [J]. PLoS One, 2011, 6(2): e16700.
|
[7] |
Akashi N, Matsumoto I, Tanaka Y, et al. Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis [J]. Mod Rheumatol, 2011, 21(3): 267-275.
|
[8] |
王欣, 刘泽林, 卢博, 等. 甲磺酸伊马替尼治疗慢性粒细胞白血病的临床效果及其对免疫功能的影响[J].中国当代医药, 2015, 22(9): 77-79.
|
[9] |
陈小华, 邱华云, 施珊珊, 等. 伊马替尼诱导原代T细胞凋亡作用机制研究[J]. 中国免疫学杂志, 2016, 32(9): 1268-1271+1275.
|
[10] |
Tan Y, Trent JC, Wilky BA, et al. Current status of immunotherapy for gastrointestinal stromal tumor [J]. Cancer Gene Ther, 2017, 24(3): 130.
|
[11] |
闫贵春, 安新, 张海永, 等. 瘢痕患者免疫功能状态研究[J]. 中国美容医学, 2011, 20(2): 247-251.
|
[12] |
莫济贤, 罗少军, 梁杰, 等. 瘢痕疙瘩形成机制的研究进展[J]. 医学综述, 2006, 12(12): 705-706.
|
[13] |
郭雷洋, 曹莫. 瘢痕疙瘩发病机制的研究进展[J]. 中国美容医学, 2012, 21(11): 1674-1677.
|
[14] |
Delahaye NF, Rusakiewicz S, Martins I, et al. Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors [J]. Nat Med, 2011, 17(6): 700-707.
|